Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Chronic leukaemia, Chronic myeloid leukaemia (CML), Leukaemia
Closed
Phase 2
This trial is for people with chronic myeloid leukaemia (CML) who have been taking nilotinib for at least 2 years. It is for people who have had treatment with a drug called imatinib (Glivec) then switched to nilotinib.
Recruitment start: 1 August 2013
Recruitment end: 6 December 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Jenny Byrne
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 17 Dec 2013
CRUK internal database number: 11149
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
